5Y3T image
Entry Detail
PDB ID:
5Y3T
Keywords:
Title:
Crystal structure of hetero-trimeric core of LUBAC: HOIP double-UBA complexed with HOIL-1L UBL and SHARPIN UBL
Biological Source:
Source Organism:
PDB Version:
Deposition Date:
2017-07-31
Release Date:
2018-05-02
Method Details:
Experimental Method:
Resolution:
2.40 Å
R-Value Free:
0.23
R-Value Work:
0.18
R-Value Observed:
0.18
Space Group:
C 1 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:RanBP-type and C3HC4-type zinc finger-containing protein 1
Chain IDs:A
Chain Length:140
Number of Molecules:1
Biological Source:Mus musculus
Polymer Type:polypeptide(L)
Description:E3 ubiquitin-protein ligase RNF31
Chain IDs:B
Chain Length:158
Number of Molecules:1
Biological Source:Mus musculus
Polymer Type:polypeptide(L)
Description:Sharpin
Chain IDs:C
Chain Length:187
Number of Molecules:1
Biological Source:Mus musculus
Ligand Molecules
Primary Citation
Cooperative Domain Formation by Homologous Motifs in HOIL-1L and SHARPIN Plays A Crucial Role in LUBAC Stabilization.
Cell Rep 23 1192 1204 (2018)
PMID: 29694895 DOI: 10.1016/j.celrep.2018.03.112

Abstact

The linear ubiquitin chain assembly complex (LUBAC) participates in inflammatory and oncogenic signaling by conjugating linear ubiquitin chains to target proteins. LUBAC consists of the catalytic HOIP subunit and two accessory subunits, HOIL-1L and SHARPIN. Interactions between the ubiquitin-associated (UBA) domains of HOIP and the ubiquitin-like (UBL) domains of two accessory subunits are involved in LUBAC stabilization, but the precise molecular mechanisms underlying the formation of stable trimeric LUBAC remain elusive. We solved the co-crystal structure of the binding regions of the trimeric LUBAC complex and found that LUBAC-tethering motifs (LTMs) located N terminally to the UBL domains of HOIL-1L and SHARPIN heterodimerize and fold into a single globular domain. This interaction is resistant to dissociation and plays a critical role in stabilizing trimeric LUBAC. Inhibition of LTM-mediated HOIL-1L/SHARPIN dimerization profoundly attenuated the function of LUBAC, suggesting LTM as a superior target of LUBAC destabilization for anticancer therapeutics.

Legend

Protein

Chemical

Disease

Primary Citation of related structures